Global Digital PCR Market Research, PCR Reaction Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
PCR allows quantification and finding of marked DNA. Polymerase Chain Reaction is an appreciated tool in analysis, clinical trials and drug discovery. Though the established markets such as the United States, France, Germany, and United Kingdom had bigger shares in the digital PCR (dPCR), the Asia-Pacific region is anticipated to develop at the CAGR of 10.7% in the future years. The growth of the dPCR market is driven by factors such as increasing geriatric population, advancements in technology, increasing incidents of infectious diseases and hereditary disorders, and increment in public-private investments and grants. Still, issues such as high cost of digital PCR devices and limitations of dPCR methods are restraining the growth of this market. Attempts for acceptance, implementation of MIQE guidelines for publishing dPCR-based research is giving an important challenge for the growth of the digital PCR (dPCR) market.
In this report, the global digital PCR market has been segmented on the basis of technology type, QPCR and digital PCR, type of product, reagents, instruments and consumables, and services and software, type of end-users includes, pharmaceutical and biotechnology companies, research laboratories and educational organizations, pharmaceutical and biotechnology enterprises, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories applications and type of application includes, clinical application, research application and forensic applications. Factors such as technological progressions in the field of dPCR, increasing acceptance of dPCR in study and medical diagnosis, and increasing connection base of dPCR instruments are driving the growth of dPCR technology market.
Geographically, North America (covering the United States and Canada) hold the largest share of global dPCR market in 2014, in second position by market share it is Europe. The digital PCR (dPCR) market in the North America is mainly driven by reasons such as increase in public and private organization support funding for development of qPCR technology, rising number of cancer patients, continuous decrease in regular cost of gene sequencing, and existence of main pharmaceutical companies in the U.S. However, monetary constraints encountered by market players are limiting the growth of the dPCR market in this region. The Asia-Pacific region is estimated to raise at the high CAGR of 10.7% in the next five years, due to factors such as emphasis of global life science companies in emergent markets, growing public and private organization support to develop novel dPCR technologies, rise of Indian genomics market, and establishment of higher cancer research in Japan.
The global digital PCR (dPCR) market is highly competitive with a large number of global as well as local market players. The global digital PCR (dPCR) market was dominated by Bio-Rad Laboratories Inc. (U.S.A.), Thermo Fisher Scientific Inc. (U.S.A.), and F. Hoffmann-La Roche, Ltd., which composed accounted for around 70 percent of the market. New product introduction in the market, partnerships, agreements, and collaborations are the major strategies adopted by most of the market companies to accomplish growth in the global digital PCR (dPCR) market.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.